Final results of a randomized phase III trial comparing cyclophosphamide, epirubicin, and fluorouracil with a dose-intensified epirubicin and cyclophosphamide + filgrastim as neoadjuvant treatment in locally advanced breast cancer: an EORTC-NCIC-SAK (Q35074719)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Final results of a randomized phase III trial comparing cyclophosphamide, epirubicin, and fluorouracil with a dose-intensified epirubicin and cyclophosphamide + filgrastim as neoadjuvant treatment in locally advanced breast cancer: an EORTC-NCIC-SAK |
scientific article |
Statements
1 reference
Final results of a randomized phase III trial comparing cyclophosphamide, epirubicin, and fluorouracil with a dose-intensified epirubicin and cyclophosphamide + filgrastim as neoadjuvant treatment in locally advanced breast cancer: an EORTC-NCIC-SAK (English)
1 reference
P Therasse
1 reference
L Mauriac
1 reference
M Welnicka-Jaskiewicz
1 reference
P Bruning
1 reference
T Cufer
1 reference
H Bonnefoi
1 reference
E Tomiak
1 reference
K I Pritchard
1 reference
A Hamilton
1 reference
M J Piccart
1 reference
EORTC
1 reference
1 reference
Identifiers
1 reference